ATP5, also known as Complex V or Mitochondrial ATP synthase, is a multi-subunit enzyme complex located in the inner mitochondrial membrane. It plays a pivotal role in oxidative phosphorylation, the process that generates ATP from ADP and inorganic phosphate, by harnessing the electrochemical gradient of protons across the inner mitochondrial membrane. The complex is composed of two main parts: the soluble catalytic core, F1, and the membrane-embedded proton channel, Fo. The F1 subunit comprises five different subunits (alpha, beta, gamma, delta, and epsilon), while the Fo subunit consists of multiple types, including subunits a, b, c, d, e, f, g, F6, and 8. The complex as a whole operates like a molecular motor, where the flow of protons from the intermembrane space back into the mitochondrial matrix provides the energy needed for ATP synthesis.
The chemical class known as ATP5 activators includes various small molecules that can either directly enhance the enzymatic activity of the ATP synthase complex or indirectly modulate its expression or functionality. These activators may work through a variety of mechanisms. Some might interact directly with the ATP synthase complex, affecting its conformation and thereby increasing its catalytic efficiency. Others may indirectly influence ATP5 activity by modulating signaling pathways that intersect with mitochondrial function or by altering substrate availability for the enzyme. For instance, certain molecules can act as electron transport chain intermediaries, enhancing substrate flow and thus indirectly influencing ATP synthase activity. Also, epigenetic regulators can modify the expression levels of the genes encoding ATP synthase subunits, leading to changes in ATP5 activity. These various types of ATP5 activators are invaluable tools for studying the intricate biochemical and cellular mechanisms underlying mitochondrial ATP production.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | ¥225.00 ¥474.00 ¥699.00 ¥1726.00 ¥2877.00 ¥5641.00 ¥338.00 | 37 | |
影响 AMPK 信号通路,从而间接影响线粒体活性,包括 ATP 合成酶。 | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | ¥677.00 ¥3046.00 ¥3949.00 | 48 | |
一种 AMPK 激活剂,可导致线粒体功能发生变化。 | ||||||
Coenzyme Q10 | 303-98-0 | sc-205262 sc-205262A | 1 g 5 g | ¥790.00 ¥2031.00 | 1 | |
作为线粒体呼吸链中必不可少的电子传递体,它可以通过影响底物的可用性来影响 ATP 合酶的活性。 | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | ¥1286.00 ¥1974.00 ¥2933.00 ¥4084.00 ¥6961.00 ¥12715.00 | ||
通过激活 PKA,它可能会影响 ATP 合酶亚基的表达或活性。 | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | ¥609.00 ¥1444.00 ¥2245.00 ¥3509.00 | 23 | |
通过改变细胞内的钙水平,这些化合物可以影响与线粒体功能交叉的钙依赖信号通路。 | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | ¥699.00 ¥1749.00 ¥3610.00 | 233 | |
通过抑制 mTOR,这种分子可以间接影响线粒体的功能和 ATP 的产生。 | ||||||
NADH disodium salt | 606-68-8 | sc-205762 sc-205762A | 500 mg 1 g | ¥1004.00 ¥1433.00 | 3 | |
影响线粒体氧化还原状态,并可通过细胞能量传感机制间接影响 ATP 合酶。 | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | ¥733.00 ¥3599.00 ¥6487.00 ¥11259.00 | 28 | |
调节基因表达,可能间接影响 ATP 合酶的表达。 | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | ¥959.00 | 9 | |
一种 HDAC 抑制剂,可能会改变影响 ATP 合酶基因表达的表观遗传格局。 |